Margaret E Macy

17PUBLICATIONS
105CO-AUTHORS
Molecular targetsRadiation therapyNeurology and neuromuscular diseasesHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.

Daniel A Morgenstern, Giuseppe Barone, Nadege Corradini

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Jun 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.

Steven G DuBois, Lucas Moreno, John Anderson

|May 02, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.

Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois

|Apr 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.

Seth E Karol, Seong L Khaw, C Michel Zwaan

|Sep 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).

Margaret E Macy, Rajen Mody, Joel M Reid

Pageof 3

Frequent Collaborators

7 joint publications

Navin R Pinto

5 joint publications

Steven G DuBois

5 joint publications

Daniel A Morgenstern

3 joint publications

Julia L Glade-Bender